marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".. my profile.

david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation..: "targeted cgrp small molecule antagonists for acute migraine therapy.".

it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. https://oakley-sunglassesformen.us/Revells-grandpa-of-Schoelman-from-Delicias?Sebreegra=280